Screener
Kyverna Therapeutics, Inc. KYTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$39.73M+11.0% | -$37.8M-0.8% | -$36.79M-6.7% | -$42.08M-46.1% | -$44.64M-67.2% | ||
| $351K-29.9% | $368K-34.6% | $415K-25.6% | $515K-2.8% | $501K+3.9% | ||
| $3.17M+46.7% | $2.7M+95.5% | $2.7M-20.9% | $2.52M+96.1% | $2.16M-5.1% | ||
| -$41.6M+7.4% | -$33.53M+9.5% | -$43.32M-57.6% | -$31.95M-32.2% | -$44.92M-76.0% | ||
| —— | —— | $2K-98.0% | $4K-99.6% | $0-100% | ||
| -$50.2M-1,000% | —— | $22.56M— | $29.17M+143% | $5.58M+105% | ||
| —— | $6.18M— | $6.18M— | $6.18M— | $6.18M— | ||
| -$101K+75.6% | $140.74M— | $1.49M— | -$649K— | -$414K-100% | ||
| -$91.9M-131% | $89.93M— | -$19.28M— | -$3.43M— | -$39.75M-121% |
FAQ
- How much cash does Kyverna Therapeutics, Inc. generate?
- Kyverna Therapeutics, Inc. (KYTX) generated -$150.4M in operating cash flow over the trailing twelve months.
- Where does Kyverna Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Kyverna Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.